Browse site A to Z

Search results

Go To Simple Search

Search Type: Criteria:

Targeting-Shared-Mechanisms-Call-1

Description: Call for Applications: Targeting shared mechanisms in immune-mediated inflammatory diseases Introduction and rationale There are more than 80 autoimmune conditions affecting over four million people in the UK. Research into immune-mediated inflammatory conditions is often pursued in a disease-specific manner, according to clinical presentation, and focusing on later stages of disease. Emerging evidence suggests there are similarities across autoimmune diseases in risk factors, immunological and pathological processes, suggesting there are significant opportunities to drive forward the development of new treatments by encouraging research that works across, or learns from, other autoimmune conditions. In May 2021, the Chernajovsky Foundation and Connect Immune Research brought the research community together to discuss targeting shared mechanisms in immune-mediated inflammatory diseases, and to catalyse new collaborations, research ideas and proposals in the area. At this meeting the immune condition research community explored and further defined priority topics in this area, as well as identifying gaps and opportunities for future research. The Chernajovsky Foundation and Connect Immune Research have come together as a consortium to address these priority topics. Examples of the topics of interest are presented below in “Areas of Interest” however the scope of this call is not limited to these areas. We will fund “pilot” grants aimed at quickly developing proof of principle new treatments for multiple autoimmune conditions, by targeting pathways common in autoimmunity. The funding will enable multidisciplinary groups of researchers to develop and progress innovative cross-disease research questions closer to benefits for people with autoimmune conditions. It is envisaged that successful candidates whose projects demonstrate the most promising outputs will be able to compete for further funding at a scale to quickly develop their research for patient benefit. Call Overview Funders Application deadline Budget available Project duration The Chernajovsky Foundation and Connect Immune Research 4pm (BST), Wednesday 13th October, 2021 Up to £100,000 Up to 12 months 01 Study Design Principles  Applications must show how the outputs from the award could lead to benefit for patients from more than one autoimmune condition.  Highly innovative, potentially risky research ideas are expected.  Translational research only, defined here as: Research that seeks to advance and apply discoveries from basic discovery research and/or clinical findings, through preclinical studies and towards clinical studies and trials. Development of drugs, diagnostics and devices are welcomed.  Milestone driven, meaning projects should focus on rapid advancement and will be required to report on a key performance indicator milestone within 6 months of project commencement.  The proposed project can include a discovery stage (no more than 4 months), however the majority of the project should be to demonstrate proof of principle.  The application should outline, if the proposed research project is successful, how the research could be translated into patient benefit in a second funding stage by briefly describing the plan for executing a translational research study or developing any resulting technologies.  The proposed research project should be collaborative, connecting immune researchers with expertise in a number of autoimmune conditions; and/or from more than one institution; and/or team members from different stages of the translational pathway, such as preclinical, translational and clinician scientists (collaborations with industrial partners are welcome but not necessary at this stage).  The lead applicant must be based in the UK and should have international recognition. They would ideally have previous experience of leading, or demonstrable ability to lead, multi-disciplinary research.  Meaningful patient and public involvement (PPI) is expected at all stages of application and award, with applications expected to seek and take into consideration the views and needs of people with autoimmune conditions. Support for PPI is available from the funders (see below). Areas of Interest Applicants should consider, but NOT be limited to, the example areas of interest, gaps and opportunities for future research that were identified by representatives of the autoimmunity research community in a workshop held in May 2021:  Revisit interferon response and autophagy to define disease drivers of these pathways for new interventions  Leveraging single cell and epigenetic analyses to determine new therapeutic concepts  Look beyond professional immune cells to the tissues to break the efficacy ceiling  Immune-neuronal bidirectional signalling in health and disease and new opportunities for intervention  Harnessing new understanding of the interplay between the gut microbiome, gut immune system and enteric nervous system Outputs from the Study  A report detailing the progress made mid-way through the project. Page 2 of 5  Submission of a final report describing the project undertaken, results and the next steps for developing the research (if any).  A presentation of results to be delivered to the Oversight Committee upon completion of the project. Outcomes from the Study  On completion the most promising projects will be invited to apply for more funding in the second phase, which may include funding for developing new methodologies or clinical trial designs potentially using repurposed current therapeutics. Application and assessment process Who can apply and what you can apply for The award will be for up to £100,000, up to 12 months with an expected starting date by Spring/Summer 2022. This call is open to teams affiliated to a university, hospital or other recognised research institution worldwide, but the lead applicant must be based at a UK institution. The application should be led by an independent lead applicant with an internationally competitive research track record. They would ideally have previous experience of leading, or demonstrable ability to lead, multi-disciplinary research. Although the applications must have a UK based lead applicant, collaborations with international and industrial partners are welcome. For information about industrial collaborations please read the guidelines from the AMRC. The proposed research project should be collaborative, connecting immune researchers with expertise in a number of autoimmune conditions; and/or from more than one institution; and/or team members from different stages of the translational pathway, such as preclinical, translational and clinician scientists (collaborations with industrial partners are welcome but not necessary at this stage). Before completing the application form please read the associated guidance documentation. Research involving patients, service users, care professionals or volunteers, or their organs, tissue or data must obtain Research Ethics Committee (REC) approval before any work can start. For any pre-clinical studies using animal models, the Funders are fully committed to the 3Rs principles (Replace, Reduce, Refine) and all our research abides by rules set out by the Home Office. Under this system, animals can only be used when there is no alternative. We are members of the Association of Medical Research Charities and sign up to their position on animal research. How will applications be assessed Applications will be assessed for eligibility to the call and then will undergo expert peer and lay review. Assessment by lay people forms a key part of the review process, as such, applicants should carefully consider the use of non-scientific language in the application form. Applicants will be invited to respond to review comments in a Rebuttal stage. Depending on the number of applications, the funders may undertake a triage stage based on reviewer feedback prior to the final panel meeting. Page 3 of 5 A panel of scientific experts and lay people will recommend an award. The criteria used to assess applications include:  Relevance to the development of collaborative strategies leading to the identification of treatments for autoimmune and immune mediated diseases.  Innovative and high-quality science  Potential for long term impact on quality of life for people currently living with autoimmune or immune mediated conditions.  Involvement of people with autoimmune or immune mediated conditions in the proposed research.  Clear description and justification of how the project methodology will address the proposed study design and deliver the required outcomes.  Strength and make-up of the research team, including multidisciplinary collaboration and proposed management arrangements.  Applicants’ track record and ability to deliver the proposed research, and facilities to conduct the proposed research  Feasibility, the potential to deliver the stated outcomes within the timescales and budget  Value for money Patient and Public Involvement We believe that involving people affected by medical conditions strengthens the quality and relevance of medical research. We encourage applicants to consider how the quality, feasibility or practicality of their proposal could be improved by involving people affected by immune conditions in its development or oversight. It is important to write a clear non-scientific summary because people affected by autoimmune conditions are involved in the review process. Please see the Applicant Guidance for further information. For further information about patient and public involvement in your application, please email patientinsight@versusarthritis.org. There are also useful resources on INVOLVE’s website: www.invo.org.uk. Contact details and how to submit an application To submit a proposal on this topic, complete the online application form at Versus Arthritis grant management system. Deadline for application Notification of Award Project Start 4pm (BST), Wednesday 13th October 2021 Early 2022 By Spring/Summer 2022 Enquiries Please contact Versus Arthritis email: research@versusarthritis.org. Page 4 of 5 Funder information (1) The Lorna and Yuti Chernajovsky Biomedical Research Foundation registered as a charity in England and Wales no.1184405 whose office is at PO Box 1198, Whitstable, Kent, CT5 9DW, UK (“the Chernajovsky Foundation”); (2) Connect Immune Research, a group of organisations that includes: a. Alopecia UK registered as a charity in England and Wales no. 1111304 and in Scotland no. SCO44702 whose registered office is at 10-12 Commercial Street, Shipley, West Yorkshire BD18 3SR (“Alopecia UK”); b. Bowel Research UK registered as a charity no. 1186061 and incorporated and registered in England and Wales as a company no. CE019377 whose registered office is c/o The Royal College of Surgeons, 35-43 Lincoln’s Inn Fields, London WC2A 3PE (“Bowel Research UK”); c. Coeliac UK is a charity registered in England & Wales (1048167) and in Scotland (SC039804) and a company limited by guarantee in England and Wales (3068044) whose registered office 3rd Floor, Apollo Centre, Desborough Road, High Wycombe, Buckinghamshire, HP11 2QW (“Coeliac UK”); d. the Juvenile Diabetes Research Foundation incorporated and registered in England and Wales as a private company limited by guarantee, company number 2071638, registered as a charity in England and Wales no. 295716 and in Scotland no. SC040123 and whose registered office is at 17/18 Angel Gate, City Road, London EC1V 2PT (“JDRF UK”); e. the British Society for Immunology incorporated and registered in England and Wales as a private limited company by guarantee, company number 03005933, registered as a charity in England and Wales no. 1043255 and in Scotland no. SC047367 whose temporary registered office is at Devonshire House, 60 Goswell Road, London, EC1M 7AD (“the BSI”); f. the Multiple Sclerosis Society incorporated and registered in England and Wales as a private company by limited guarantee, company number 07451571, registered as a charity in England and Wales no. 1139257 and in Scotland no. SC041990 whose registered office is at 10 Queen Street Place, London EC4R 1AG (“the MS Society”); g. The Psoriasis and Psoriatic Arthritis Alliance is incorporated and registered in England and Wales as a private company by limited by guarantee, company number 06656347, registered as a charity in England and Wales no. 1118192 and whose registered office is at Acre House, 11-15 William Road, London NW1 3ER (“the PAPAA”); h. Versus Arthritis incorporated and registered in England and Wales as a private company limited by guarantee, company number 490500, registered as a charity in England and Wales no. 207711 and in Scotland no. SC041156 whose registered office is at Copeman House, St Mary’s Court, St Mary’s Gate, Chesterfield S41 7TD (“Versus Arthritis”), (together CIR). Page 5 of 5
Url: /Media/Southampton-Clinical-Research/Downloads/Targeting-Shared-Mechanisms-Call-1.pdf

Expression of interest form

Description: Fellowship Expression of Interest This Expression of Interest (EOI) form should be completed by anyone considering an application for an external fellowship, at any level, through either: * University of Southampton’s Faculty of Medicine or School of Health Sciences (Faculty of Environmental and Life Sciences), or * University Hospital Southampton, or * other local NHS Trust The information you provide will enable your Faculty/School and Trust to guide you and, where appropriate, to provide ongoing support for your application and project. Fellowship Expression of Interest Process Please complete the form as fully as possible; there will be later opportunities to resolve unknown details. Return the form with a short academic CV to the proposed employing organisation, i.e. the proposed host organisation for the fellowship. (In the case of Trusts other than UHS, please send to University of Southampton, regardless of employing organisation.) * University Hospital Southampton: researchgrants@uhs.nhs.uk * University of Southampton or other NHS Trust: * Faculty of Medicine: biomedicalresearch@soton.ac.uk (resmed) or * School of Health Sciences (Faculty of Environmental and Life Sciences): hsapp@soton.ac.uk The EOIs will be reviewed by either the relevant University fellowship champion(s) or the Director of Southampton Academy of Research (SoAR) for University Hospital Southampton hosted fellowships. The reviewer(s) will suggest appropriate next steps and identify where applicants can find suitable support. Important Information: * To help coordinate support, the applicant’s information may be shared between a Faculty/School and a Trust. * If you DO NOT want your EOI to be shared with a particular organisation please highlight this in your email when you submit the EOI. * The Faculty/School and University Hospital Southampton aim to provide support provided the EOI is submitted at least 12 weeks before the funder deadline. * Developing a robust proposal takes a long time and applicants are encouraged to submit an EOI as early as possible. Applicants should allow a minimum of six months or, ideally, a year for writing the application, in order to take full advantage of all possible training, mentoring and support available. * The Faculty of Medicine, the School of Health Sciences and the University Hospital Southampton reserve the right not to approve applications from applicants who have not followed this process. Fellowship Expression of Interest Form Applicant Information Applicant Name Click or tap here to enter text. Career Stage Pre-doctoral/Training (for PhD students) / Early Career / Transition to independence / Transition to leadership / Established leader Click or tap here to enter text. Current employer University of Southampton or named NHS Trust Click or tap here to enter text. Current Faculty/School (UoS) or Division (Trust) Click or tap here to enter text. Current job/role(s) Title of current post Click or tap here to enter text. Select relevant role(s) Clinical Research Education Current line manager Please also confirm that you have discussed your intention to apply for a fellowship with your current line manager Name: Job title: Contact details: Fellowship details Proposed funder and scheme (if known) Proposed funder: Proposed scheme: Are you considering any other funders/schemes? If yes, who? Anticipated submission date (if known) Click or tap to enter a date. Duration of proposed fellowship and % of your time it will take (wte) Click here to enter text. Details of any additional academic institutions to be involved Click or tap here to enter text. Proposed Supervisor/Mentor /Scientific advisor If you can, please provide names of supervisors/mentors/scientific advisors you think might potentially play a role in your fellowship application Click or tap here to enter text. Proposed working title of research project Click or tap here to enter text. For external applicants only (i.e. not UoS, UHS or other local NHS Trust): Why have you chosen to undertake your Fellowship in Southampton? suggested word count: 200 words Click or tap here to enter text. Fellowship host information Please complete only the green column if University of Southampton will employ you during your proposed fellowship - University of Southampton will be your anticipated employer. Complete only the blue column if University Hospital Southampton or another NHS Trust will employ you during your proposed fellowship – NHS will be your anticipated employer. If your fellowship requires both an academic host (university of Southampton) and a clinical Trust partner (for example the NIHR Integrated Clinical Academic fellowships scheme, including Pre-doctoral Clinical Academic Fellowships) then please complete both green and blue columns. Anticipated employer – choose either UoS or NHS Trust unless your identified scheme requires both University of Southampton Click or tap here to enter text. NHS Trust (specify) Click or tap here to enter text. UoS Faculty / NHS Trust Division Choose an item. Choose an item. UoS School / NHS Care group Select: Choose an item. Care group (specify) Click or tap here to enter text. Anticipated Faculty/School research group or theme Specify: Click or tap here to enter text. Have you discussed your intention to apply for a fellowship with the head of research group or theme lead? Choose an item. Not applicable for Trust If you have any feedback regarding this form and the EOI process, please send to biomedicalresearch@soton.ac.uk or researchgrants@uhs.nhs.uk Expression of Interest Form for Fellowships July 2019_final
Url: /Media/Southampton-Clinical-Research/Grants/Download/Expression-of-interest-form.docx

Current funding calls

Description: Auto Generated Title Here you can find new grant funding calls from various funders. Links on the right will take you directly to other calls with specific key funders. Keep up-to-date with COVID-19 funding calls and resources The Health Research Authority is publishing details about all approved COVID-19 research studies, within their dedicated COVID-19 section. More information New research priorities identified for aerosol generating procedures related to COVID-19 New funding opportunities are likely to result from the identification of a new set of research priorities relating to the COVID-19 pandemic. Details will be published here as they are made available. Five new research priorities have been identified through the NIHR expert review process, with the purpose of providing evidence to understand and assess aerosol generation and the infective risk associated with individual AGPs as well as broader questions about airborne transmission of COVID-19 in healthcare settings. Understanding the fundamental aerobiology Including virus distribution and viability in airborne particles. Risk factors for transmissibility Understanding and quantifying the risk of transmissibility across multiple domains (including patient, procedure, environment, pathogen and healthcare professional factors) in order to generate a clinically applicable risk model. Mitigating precautions and their components Identifying which mitigating precautions are important and how they work: to include clinical efficacy testing of PPE, environmental measures (e.g. ventilation, filtration), and other barrier devices. Transmission of COVID-19 and other pathogens Investigating the contribution of inhalation versus inoculation for infection risk from AGPs and other healthcare interventions. Understanding infective risk perception, behaviours and acceptability of mitigation strategies This will include diverse groups of healthcare workers, patients and the public. More information EPSRC - healthcare technologies investigator-led grant Funder: Engineering and Physical Sciences Research Council Closing date: n/a - OPEN CALL Healthcare technologies investigator-led research grants are for researchers at UK higher education institutions, research council institutes, UKRI-approved independent research organisations and NHS bodies. We strongly encourage collaboration with relevant healthcare professionals, other researchers, industry, the public sector and other relevant partners. We are looking for researchers in engineering, physical sciences, information and communications technologies (ICT) and mathematical sciences who want to apply their expertise to healthcare challenges. Projects can range in size from small short-term grants to multi-million-pound research programmes lasting several years. There is no limit on the size of the grant or length of the project. We will award 80% of the full economic costs of the project, and your organisation must agree to find the balance. More information UKRI - addressing limitations in manufacturing nucleic acid therapeutics Funder: UKRI Closing date: n/a - OPEN CALL Apply for funding to set up a research consortium addressing challenges in the manufacture of nucleic acid therapeutics. Current manufacture challenges include but are not limited to: scale of production product purity, stereochemistry and reproducibility sustainable production novel chemistries synthesis efficiency analytical oligonucleotide characterisation. The consortium can include academic and industrial organisations in the UK and abroad. The lead organisation must be UK-based. More information NIHR - NICE rolling call for research studies addressing NICE research recommendations Funder: NIHR Closing date: various, see below The NIHR research programmes (EME, HTA, PHR and HS&DR) are interested in receiving applications to meet recommendations in research identified in NICE guidance published from 2015 onwards (for the purposes of this call, NICE guidance includes the following: clinical, social care, public health, technology appraisals, interventional procedures and diagnostics). Proposals must be within the remit of one of the participating NIHR research programmes and the primary outcome measure must be health related. Proposals must be within the remit of at least one of the following participating NIHR Programmes. However, applications which span the remit of one or more programme are welcome. Health Technology Assessment (deadline 05 January 2022) Public Health Research (deadline: 30 November 2021) Sight Research UK - translational research award Funder: Sight Research UK Closing date: 30 November 2021 Sight Research UK funds pioneering research into the causes of eye disease, in order to develop better prevention methods and more effective treatments for children and adults. The Translational Research Award supports research projects with a clearly defined pathway to achieving patient benefit. Its goal is to help to accelerate the translation of scientific findings to the early stages of development of new therapies, devices, and diagnostics. Sight Research UK welcomes projects that have robust commercial potential, likely to attract large scale follow-on funding from other charitable, statutory or industry funders. Eligible projects must: Be based on unmet clinical need. Aim to generate lead candidates for therapeutic applications. Be relevant to and highly promising in the clinical setting (these are not early stage, proof of concept studies, instead they have already shown that the idea might be used as therapy in man). Be focused on assessing properties such as potency, efficacy, selectivity, or bioavailability of compounds identified by previous research as potentially strong candidates for therapeutic applications. Have a clear pathway to apply for funding such as the MRC Confidence in Concept, MRC Development Pathway Funding Scheme type funding and other similar funding schemes. More information NIHR Public Health Research Programme - researcher-led workstream Funder: NIHR Closing date: 30 November 2021 The Public Health Research (PHR) Programme funds research to generate evidence to inform the delivery of non-NHS interventions, intended to improve the health of the public, and reduce inequalities in health. The Public Health Research Programme are accepting stage 1 applications to their researcher-led workstream. More information NIHR Public Health Research Programme - dementia research call Funder: NIHR Closing date: 30 November 2021 This National Institute for Health Research (NIHR) call invites proposals for dementia research to address important health and social care questions. Research could involve any aspect of prevention, diagnosis, treatment, support or care, and related health and social care services. Applications which involve investigators spanning a range of specialties are encouraged and partnership with national charities welcomed. The HTA and EME programmes are also featuring this research area - see below 7 December and 5 January. More information British Geriatrics Society - specialist registrar research start-up grants Funder: BGS Closing date: 30 November 2021 The British Geriatrics Society Specialist Registrar Research Start-Up Grant scheme provides grants to individuals who want to get a research project started. The aim is to allow young doctors to follow through ideas at relatively short notice, to enable advantage to be taken of unique or rare opportunities, and to provide short-term assistance to speculative and innovative research that may be at an early stage. The grants may support a complete project or, where appropriate, support a pilot study to enable an application for external project grant support to be made. The grants are eligible for National Institute for Health Research (NIHR ) non-commercial partner status. More information NIHR Development and Skills Enhancement Award Round 8 Funder: NIHR Closing date: 30 November 2021 The Development and Skills Enhancement Award (DSE) provides a maximum of 1 year of funding for post-doctoral NIHR Academy Members to gain skills and experience for the next phase of their research career. As an applicant you will be required to demonstrate the new skills and experience you hope to gain through the award, and how it will benefit your future career in research. More Information NIHR PHR Programme 21/560 - James Lind Alliance priority setting partnerships rolling call Funder: NIHR Closing date: 30 November 2021 The Public Health Research (PHR) Programme funds research to generate evidence to inform the delivery of non-NHS interventions, intended to improve the health of the public, and reduce inequalities in health. The JLA Priority Setting Partnerships facilitate patients, carers and clinicians to work collaboratively to identify research priorities in particular areas of health and care. Their aim is to ensure that health research funders are aware of the issues that are important to the people who need to use the research in their daily lives. The NIHR PHR programme recognises the importance of the research priorities identified by the James Lind Alliance Priority Setting Partnerships and is interested in receiving high-quality applications which address them More information MRC - advancing adolescent mental health and wellbeing research Funder: Medical Research Council Closing date: 1 December 2021 Apply for funding to help improve research in the field of ‘ adolescence, mental health and the developing mind ’ through: methodological innovation capability building This opportunity will support projects that help researchers in delivering more relevant, valid, reproducible, mechanistically informed, multi-level and translationally scalable research in adolescent mental health over the next decade. Outputs from these projects may also allow new research questions to be investigated. Proposals should: address a clear area of unmet need with regard to existing research methods, concepts, tools or measures identify innovative new approaches for conducting mental health and wellbeing research with adolescents. More information NIHR - Health Technology Assessment Programme, commissioned workstreams Funder: NIHR Closing date: 1 December 2021 21/532 Intensive Interaction for children and young people with profound and multiple learning disabilities 21/534 Surgical management of successfully reduced incarcerated inguinal hernia in children 21/535 Follow-up strategy after radical treatment for prostate cancer 21/536 Sodium bicarbonate in neonatal care 21/537 Neuroendoscopic lavage for preterm babies with post-haemorrhagic ventricular dilatation 21/538 Benefits and harms of reduced dose oral isotretinoin in the management of acne vulgaris 21/539 Benefits and harms of maintenance therapy for refractory acne vulgaris or previous relapses by reduced dose isotretinoin regimens 21/540 Pharmacological treatments for low back pain or sciatica 21/542 Medication to manage sexual preoccupation in sex offenders 21/552 Microsuction compared with irrigation to remove earwax Diabetes UK - small grants and project grants Funder: Diabetes UK Closing date: 1 December 2021 Diabetes UK aims to improve lives through pioneering research into all forms of diabetes and diabetes-related complications. The work they support helps us understand the causes of diabetes, bring about life-changing breakthroughs in care, treatment and prevention and brings us closer to a cure. The following calls are open for application: Project grants : For high quality, hypothesis driven diabetes research projects, lasting up to five years and costing less than £ 500,000. Current research priority areas are: (1) New glucose monitoring technologies in inpatient care; (2) Understanding the pathogenesis of diabetes that develops atypically, or in minority populations Deadline for applications: 01 December 2021 Early-Career Small Grants : supports early-career basic scientists and members of Allied Health Professions to undertake small research projects related to diabetes. The scheme will enable scientists at an early stage in their career to develop their work and go on to obtain additional grant funding from other organisations. Nurses, pharmacists and members of the Allied Health Professions who meet the eligibility criteria may apply through this scheme. Deadline for applications: 01 December 2021 Diabetes UK & Great Foundations - addressing the issues in foot care which lead people with diabetes developing foot conditions Funder: Diabetes UK and Great Foundations Closing date: 1 December 2021 Diabetes UK and Great Foundations are inviting proposals addressing the issues which lead to people with diabetes developing ulcers or other diabetes-related foot conditions and these then progressing further. Preventing foot ulcers, amputations and other severe foot complications in people with diabetes is a key priority for the Diabetes Research Steering Group. There is a clear need for innovative approaches to do this, but these need to consider the findings of previous studies and address factors in foot care which may have previously not been subject to research. These include social factors which present significant barriers to care or treatment, the difficulty people with neuropathy have in detecting and adapting to foot conditions and the need for effective and rapid referrals for foot care when it is needed. More Information Versus Arthritis & MSK TRC - accelerating new treatments Funder: NIHR/Versus Arthritis Closing date: 1 December 2021 As part of the UK Musculoskeletal Translational Research Collaboration (MSK TRC) we are launching the second call for research projects focused on mechanistic experimental/translational medicine studies in humans across the areas of prevention, diagnosis or treatment that are aimed at priming the next transitional step. More information NIHR - Research Professorships, round 12 Funder: NIHR Closing date: 1 December 2021 The NIHR Research Professorships aim to fund research leaders of the future to promote effective translation of research and to strengthen health, public health and care research leadership at the highest academic levels. The scheme is open to all professions and all Higher Education Institutions (HEI), in partnership with NHS organisations, or other providers of health, public health and/or care services based in England, to nominate health, public health and social care researchers and methodologists with an outstanding research record of clinical and applied health research and its effective translation for improved health. Candidates must demonstrate they are on a steep career trajectory to become a research leader having spent no more than five years at their current level of seniority at the time of application. More information Davos Alzheimer's Collaborative - increasing cognitive assessment rates for older adults Funder: Davos Alzheimer's Collaborative Closing date: 1 December 2021 The Davos Alzheimer ’ s Collaborative (DAC) is funding innovators who can increase cognitive assessment rates for older adults. The proposed approach should aim to increase the percentage of patients age 65+ who are provided with a standardized cognitive assessment in selected health system(s) or implementation site(s). It should indicate which health system(s) or other implementation partner(s) your team plans work with. It can utilize any cognitive assessment solution, technology or tool with clear evidence of efficacy and potential for sustainability. DAC is agnostic on the exact mechanism for cognitive assessment. Teams can develop a novel solution or implement an existing solution. More information Psoriasis Association: Research Grants Funder: Psoriasis Association Closing date: 3 December 2021 The Psoriasis Association will consider applications that have clear relevance to its aim 'to promote and fund research into the causes, nature and care of psoriasis and to publish and disseminate the results of that research'. The Psoriasis Association offers the following: PhD studentships : Supports the training of graduate students leading to the presentation of a PhD Cecil King Memorial Award : For projects where the principal researcher is under 35 years of age, or within the first five consecutive years, at the time of application, of either their first permanent independent academic research post or a named limited-tenured/fixed-term academic research post, obtained in open competition More Information Southampton Academy of Research - training awards Funder: NIHR SoAR Closing date: 14 December 2021 SoAR funding awards 2021/2022 are now open for applications: Internship award - 6 months Transitional award - 12 months Post doctoral award - 6 or 12 months Further information is available by email NIHR - efficiency and mechanism evaluation programme - new commissioned calls Funder: NIHR Closing date: 7 December 2021 The Efficacy and Mechanism Evaluation (EME) Programme funds ambitious studies evaluating interventions with potential to make a step-change in the promotion of health, treatment of disease and improvement of rehabilitation or long-term care. Within these studies, EME supports research in the mechanisms of diseases and treatments. EME is a partnership between the Medical Research Council (MRC) and the NIHR. The EME Programme is accepting stage 1 applications to their commissioned workstream for the following funding opportunities: Mechanisms of action of health interventions Efficacy trials in regenerative medicine Early detection of disease NIHR efficacy and mechanisma evaluation programme - dementia research call Funder: NIHR Closing date: 7 December 2021 This National Institute for Health Research (NIHR) call invites proposals for dementia research to address important health and social care questions. Research could involve any aspect of prevention, diagnosis, treatment, support or care, and related health and social care services. Applications which involve investigators spanning a range of specialties are encouraged and partnership with national charities welcomed. The PHR and HTA programmes are also accepting proposals in this call - see 30 Nov and 5 Jan. More information NIHR NICE rolling call for research studies addressing NICE research recommendations Funder: NIHR Closing date: 7 December 2021 The Efficacy and Mechanism Evaluation Programme is accepting Stage 1 applications for the NICE rolling call for research studies addressing NICE research recommendations. The EME Programme is interested in receiving applications to meet recommendations in research identified in NICE guidance published from 2015 onwards (for the purposes of this call, NICE guidance includes the following: clinical, social care, public health, technology appraisals, interventional procedures and diagnostics). More information NIHR efficacy and mechanism evaluation programme - researcher-led workstream Funder: NIHR Closing date: 7 December 2021 The Efficacy and Mechanism Evaluation (EME) Programme funds ambitious studies evaluating interventions with potential to make a step-change in the promotion of health, treatment of disease and improvement of rehabilitation or long-term care. Within these studies, EME supports research in the mechanisms of diseases and treatments. EME is a partnership between the Medical Research Council (MRC) and the NIHR. The Efficacy and Mechanism Evaluation (EME) Programme is accepting stage 1 applications to their researcher-led workstream. Applications are sought for research into interventions that are based or used by the NHS and its partners. More information NIHR 21/561 James Lind Alliance Priority Setting Partnerships rolling call (EME programme) Funder: NIHR Closing date: 7 December 2021 The Efficacy and Mechanism Evaluation (EME) Programme is accepting stage 1 applications to this funding opportunity. The programme recognises the importance of the research priorities identified by the James Lind Alliance (JLA) Priority Setting Partnerships (PSP) and are interested in receiving high-quality applications which address them. More information Royal College of Surgeons of England - pump priming grants Funder: Royal College of Surgeons Closing date: 7 December 2021 The Royal College of Surgeons of England is offering a limited number of awards of up to £ 10,000 to newly appointed consultants, senior lecturers and post-doctoral trainees (appointed since 2015) in surgery who are working at hospitals and universities within the UK. The aim of the awards is to give assistance to such surgeons in the early stages of their independent research careers. Awards may be used, amongst other things, for small items of equipment, for consumables or for technical assistance. All applicants must be members or fellows of The Royal College of Surgeons of England. Applicants must be consultants, senior lecturers or post-doctoral trainees (appointed since 2015) working in surgery in the UK. More information CRUK: Early Detection and Diagnosis Project Award Funder: CRUK Closing date: 8 December 2021 Early Detection and Diagnosis Project Awards fund science to drive transformational change in how and when early cancers and pre-cancerous states are diagnosed. Early detection and diagnosis (ED&D) research seeks to detect and diagnose consequential precancerous changes and cancer at the earliest possible point at which an intervention might be made, reducing the burden of late-stage disease. ED&D projects will support discovery and translational/clinical research which is mindful of the clinical and population context. More Information NIHR i4i - product development awards, call 23 Funder: NIHR i4i Closing date: 8 December 2021 The NIHR Invention for Innovation (i4i) Programme supports the preclinical and clinical development of medical technologies in areas of existing or emerging patient need. The i4i programme invites proposals to Call 23 of its researcher-led Product Development Awards (PDA). PDAs fund the development of disruptive early-stage medical technologies that address existing or emerging healthcare needs. They support translational projects developing medical devices, in vitro diagnostics and digital health technologies that are patient-focused and for ultimate NHS use. More information Wessex REACH - peer support funding Funder: Wessex REACH Closing date: 10 December 2021 A small amount of funding is available to groups of researchers who wish to create a space for thinking, connecting and problem solving with their peers. Anyone currently working in healthcare, social care or in healthcare-related research in Wessex is eligible. Groups can apply for up to £ 500 to be used over a 1 year period. Send a short summary (up to 500 words) detailing your group, reasons for applying, planned activities, objectives and how they align with building research capacity in Wessex, and budget to info@wessexreach.org.uk . For more detail, contact Beth Stuart . More information THIS Institute environmental sustainability fellowship Funder: The Healthcare Improvement Studies (THIS) Institute Closing date: 15 December 2021 Fellowships to enable individuals to conduct research that will help the NHS increase its capacity to improve environmental sustainability. Focus areas in scope could include energy use, waste disposal, procurement and supply chains, operational processes, transport, hygiene practices, equipment and technology, care processes, device or building design, as well as many other research questions relevant to improving sustainability. Findings should be generalisable or transferable and should contribute to scholarly work as well providing real actions that can be implemented. More information CRUK: Prevention and Population Research Project Awards Funder: CRUK Closing date: 15 December 2021 Prevention and Population Research Awards provide support for focused research proposals centred on key questions in prevention and population research. More Information Closing the Gap collaboration fund Funder: UKRI Closing the Gap Network Closing date: 20 December 2021 Funding to support and encourage new and emerging collaborations in the area of severe mental ill health to develop new research proposals that could be funded through the Closing the Gap Network Plus funds or through other funding bodies. More information Action for A-T - research grants Funder: Action for A-T Closing date: 3 January 2022 Action for A-T funds medical research to speed up the process of identifying a cure for Ataxia Telangiectasia (A-T) or treatments that delay or prevent the disabling effects of this devastating childhood condition. Applications are invited for high quality research projects that have the potential to lead to treatments and cures for Ataxia-Telangiectasia. More information NIHR Health Technology Assessment Programme Researcher-led workstream Funder: NIHR Closing date: 5 January 2022 The Health Technology Assessment Programme is accepting stage 1 applications to their researcher-led evidence synthesis workstream, 21/554. More Information NIHR Health Technology Assessment Programme Researcher-led workstream Funder: NIHR Closing date: 5 January 2022 The Health Technology Assessment Programme is accepting stage 1 applications to their researcher-led workstream, 21/555. More Information NIHR 21/558 NIHR James Lind Alliance Priority Setting Partnerships rolling call (HTA Programme) Funder: NIHR Closing date: 5 January 2022 The Health Technology Assessment (HTA) Programme is accepting stage one applications to this funding opportunity. The programme recognises the importance of the research priorities identified by the James Lind Alliance (JLA) Priority Setting Partnerships (PSP) and are interested in receiving high-quality applications which address them. More Information NIHR 21/559 Dementia research call - Health Technology Assessment (HTA) Programme Funder: NIHR Closing date: 5 January 2022 The Health Technology Assessment (HTA) Programme is accepting stage one applications to this funding opportunity. Dementia is a growing challenge that has become one of the most important health and social care issues facing the world. We need to continue building the evidence base, to improve the lives of people affected by dementia. More Information NIHR Policy Research Programme - evaluation of new funding for inpatient detoxification beds Funder: NIHR Closing date: 6 January 2022 The NIHR funds policy research to enable evidence informed policy making in health and social care. The PRP Programme invites applications for a single research project to qualitatively evaluate an initiative to increase provision of inpatient detoxification to improve drug recovery. It is expected this will be based on in-depth interviews with about 30 inpatients and 30 healthcare professionals with initial contact needed in October-December 2021, a follow-up directly after the detox and a further follow-up after 6 months. The project will complement a quantitative analysis being carried out by Public Health England (PHE). More information NIHR James Lind Alliance Priority Setting Partnerships rolling call (HS&DR programme) Funder: NIHR Closing date: 11 January 2022 The Health Services and Delivery Research (HS&DR) Programme is accepting stage one applications to this funding opportunity. The programme recognises the importance of the research priorities identified by the James Lind Alliance (JLA) Priority Setting Partnerships (PSP) and are interested in receiving high-quality applications which address them and are within the scope of the programme. The JLA Priority Setting Partnerships facilitate patients, carers and clinicians to work collaboratively to identify research priorities in particular areas of health and care. Their aim is to ensure that health research funders are aware of the issues that are important to the people who need to use the research in their daily lives. The NIHR research programmes fund research across the National Health Service (NHS), public health and social care to meet the needs of those who plan, provide and receive care and services. The programmes recognise the importance of the research priorities identified by the James Lind Alliance Priority Setting Partnerships and are interested in receiving high-quality applications which address them. More information NIHR Health Services and Delivery Research Programme (standard researcher-led) Funder: NIHR Closing date: 11 January 2022 The Health Services and Delivery Research (HS&DR) Programme aims to produce rigorous and relevant evidence to improve the quality, accessibility and organisation of health and social care services. The HS&DR Programme is accepting stage 1 applications to their researcher-led workstream. The researcher-led workstream welcomes Stage 1 proposals on topics or research questions identified by researchers within the programme ’ s remit. The aim is to fund research that will lead to improvements in health services that will be of greatest benefit to the NHS and to patients. We are interested in a range of types of research including primary research and evidence synthesis. More information NIHR Invention for Innovation - challenge awards, call 13 Funder: NIHR Closing date: 12 January 2022 The Challenge Awards will fund investigations of MedTech innovations in healthcare settings. The aim is to shorten the evidence gap between the safety/efficacy typical of a newly or nearly CE-marked technology and what is required for decisions by commissioners and regulators. At the same time, this will de-risk the product for follow-on investment. Please note that nearly CE-marked technologies refers to technologies that are currently under Notified Body assessment, whereby all of the mandatory testing has been completed. More information Medical Research Foundation - adolescent dermatology Funder: Medical Research Foundation Closing date: 12 January 2022 The aim of this grant is to increase understanding of the disease mechanisms underpinning skin disorders of relevance to adolescents, and improve diagnosis, treatment and management of these diseases. MRF are inviting applications from clinicians who have the potential to be the research leaders of the future, to support research that will increase understanding of the disease mechanisms underlying adolescent skin disorders. Researchers whose work may lead to better understanding of prevention, treatment or management of these disorders are welcome to apply. More information NIHR Programme Development Grants - competition 32 Funder: NIHR Closing date: 13 January 2022 NIHR Programme Development Grants (PDG) are designed to enable a research team to carry out targeted preparatory work to develop a competitive Programme Grants for Applied Research (PGfAR) funding application. They can also be used to further develop an existing or ongoing PGfAR-funded programme of research. Programme Development Grants are designed to increase the rate and number of successful applications for a full Programme Grant by supporting the completion of the necessary preparatory work to suitably position the research team to submit a competitive Programme Grant application. Applications to PDG are made with the support of an NHS body and other providers of NHS services in England. If an application is successful, a contract will be placed with that organisation for delivery of the research and all funds for the research will be paid to the NHS organisation or other provider of NHS services. more information NIHR Population Health Career Scientist Award Funder: NIHR Closing date: 13 January 2022 The NIHR has launched the Population Health Career Scientist Award (PHCSA), a UK-wide initiative to enable senior researchers to make the next step to Reader/Professor level in their host institutions. The PHCSA forms part of a series of initiatives and investments by NIHR to enable local government to become more research active. This new award will help answer the most important research questions facing decision-makers at local and national levels to improve health and reduce inequalities. There is a desire to attract applicants representing the wide range of disciplines which undertake research in areas which impact the determinants of health (e.g. environmental science, mathematics, architecture, engineering, geography, education, social sciences, social policy, arts). More information NIHR Advanced Fellowship Funder: NIHR Closing date: 13 January 2022 The NIHR Advanced Fellowship funds post-doctoral individuals from a range of health and social care professions who have not yet been awarded a chair. Whether you are someone who has recently been or about to be awarded a PhD, or someone with several years of post-doctoral experience, you could be eligible to apply for an Advanced Fellowship. The Fellowship funds: full salary support, including protected time to concentrate on research research costs a bespoke training and development programme to meet individual needs Applicants who are active clinicians or social workers can request for up to 40% of their time to be dedicated to clinical service/development/practice, which will be covered by the Fellowship. We are particularly welcoming applications from researchers looking to undertake research in: Multiple Long Term Conditions – Multimorbidity (MLTC-M) Dementia More Information Royal Institute for Deaf People - fellowships Funder: RNID Closing date: 13 January 2022 The RNID Fellowship scheme aims to build research capacity in hearing research, by supporting the career development of the UK ’ s most talented new ‘ investigators ’ towards becoming independent scientists. Applications are invited in any of the following areas: Research to underpin the development of treatments for hearing disorders, including tinnitus . Including, but not limited to, medical devices, pharmacological treatments, genetic or cellular therapies – treatments should aim to prevent hearing loss, restore auditory function or silence tinnitus. Research to improve how new treatments for hearing disorders, including tinnitus, are developed and tested . Including research to improve the measurement of auditory function or tinnitus, or to develop models of human hearing disorders, including tinnitus. More information Cancer Research UK drug development project Funder: CRUK Closing date: 14 January 2022 Drug Development Projects are not grant funding awards. The funding is there to develop new cancer treatments from preclinical development through to early phase patient trials. Applicants must have a novel cancer agent needing preclinical and/or clinical development and have supporting in vivo efficacy data. All technology areas are considered, including small molecule, biological and other therapeutics. More information NIHR Doctoral Fellowships - round 7 Funder: NIHR Closing date: 18 January 2022 NIHR Doctoral Fellowships provide funding for individuals to undertake a PhD in an area of NIHR research. As part of the creation of the NIHR Academy, four broad Strategic Themes have been identified which represent key priority areas for the NIHR Academy. Applications received under these Themes will still have to meet the same quality threshold required for funding, but will be given priority if the number of fundable applications exceeds the maximum that can be funded. The Themes are: social care, public health, mental health and health data science. More information Parkinson's UK / Rosetree Trust joint senior research fellowship Funder: Parkinson's UK & Rosetree Trust Closing date: 19 January 2022 Parkinson's UK and Rosetrees Trust are jointly funding the Joint Senior Research Fellowship to support early career researchers with an excellent track record in novel cell culture techniques to establish a highly innovative independent drug discovery programme and become research leaders of the future. With this fellowship scheme, the funders are keen to support the progression of neuroprotective treatments for Parkinson's through the development and use of novel cell culture platforms. More information British Heart Foundation - clinical study grants Funder: British Heart Foundation Closing date: *various* see below For clinical trials and observational studies of specific patient groups, usually costing more than £ 350,000 or lasting more than 3 years. The Clinical Study Grant supports funding for: Interventional clinical trials: trials of specific interventions or pathways of care for the prevention, diagnosis and treatment of cardiovascular disease. Interventions include drugs, surgery, devices, psychological, physical and educational interventions. Observational studies of specific patient groups that are hypothesis led and address a defined clinical question(s) over a fixed timescale (up to 5 years). The population of interest should be a patient population, who will usually be recruited within the NHS. The study should have a predefined outcome(s) that will lead to changes in clinical management directly or will inform the development of a clinical trial to test an intervention. Clinical studies can include a mechanistic evaluation, either as a substudy within a clinical trial or as part of an observational study. Closing dates for proposals: 19 January 2022, 11 May 2022 More information British Heart Foundation - consultant research awards Funder: BHF Closing date: 19 January 2022 This new scheme aims to provide protected time to clinically active consultants to undertake substantial cardiovascular research activities in addition to their clinical roles. They provide up to 2 years full-time equivalent of salary support for the primary applicant, to backfill an equivalent number of NHS PAs. This grant can be taken on a full-time basis or spread across up to 5 years, and additional support costs be also be applied for in each year of an award. There will be two fixed calls for this scheme each year. More information Royal Commission for the Exhibition of 1851 - research fellowships Funder: Royal Commission 1851 Closing date: 19 January 2022 The Royal Commission for the Exhibition of 1851 awards Fellowships for advanced study and research in science, engineering, the built environment and design. 1851 Research Fellowships are intended to give early career scientists or engineers of exceptional promise the opportunity to conduct a research project of their own instigation; an ultimate objective is to contribute to the knowledge base required for a healthy and innovative national culture. Around eight awards are made each year. More information Alzheimer's Research UK - senior research fellowship Funder: Alzheimer's Research UK Closing date: 21 January 2022 Senior Research Fellowships are designed to retain excellent clinical and non-clinical researchers who have a track record of nationally competitive research, and clear plans to manage their own independent research group and become internationally recognised within the field of biomedical dementia research. The purpose of Senior Research Fellowships is to foster both clinical and non-clinical researchers in their “ transition to independence ” . Prospective applicants should a have a strong track record of original and productive research in their area (as evidenced by senior author publication(s) or other equivalent outputs), which shows productivity and impact across past appointments (typically at least one previous post-doctoral appointment). More information Alzheimer's Research UK - major projects Funder: Alzheimer's Research UK Closing date: 21 January 2022 Alzheimer ’ s Research UK is a research charity dedicated to causes, diagnosis, prevention, treatment and cure of Alzheimer ’ s. ARUK work across four key areas of action: Understand the diseases that cause dementia; diagnose people earlier and more accurately; reduce risk, backed by the latest evidence; treat dementia effectively. The Major project grant scheme provides funds for high quality research projects. It is provided to cover salaries (research, technical, students etc), equipment, animal costs and running costs (consumables, travel etc). More information NIHR Health Services & Delivery Research Programme - improving choice, access and uptake of contraception Funder: NIHR Closing date: 21 January 2022 The Health Services and Delivery Research (HS&DR) Programme aims to produce rigorous and relevant evidence to improve the quality, accessibility and organisation of health and social care services. The HS&DR Programme is interested in receiving applications to understand the impact of the pandemic on women ’ s, including transgender and non-binary people ’ s, choices, access and their attitudes and preferences towards contraception, especially towards long-acting reversible contraceptives. It is also important to understand their experiences of initial access to contraception in both general practice and sexual and reproductive health services. We are also interested in research that explores women ’ s, including transgender and non-binary people ’ s, experiences of using these services, and the extent to which their care is fragmented or well-coordinated, and what this indicates in terms of how service provision may need to change to meet future needs. Research into understanding experiences of these services in the context of rapid changes to services from face-to-face to remote during the COVID-19 pandemic is also of interest. More information Paget's Association - research grants Funder: Paget's Association Closing date: 25 January 2022 The Paget's Association is a national UK charity providing information and support to all those affected by Paget ’ s Disease of Bone. The Association funds quality research, raises awareness and supports professionals to achieve excellence in care and research. The Paget ’ s Association invites applications for Research Project Grants in all areas of Paget ’ s Disease of Bone. Collaborative research is strongly encouraged, including through our Paget ’ s Association Centres of Excellence (PACEs). More information UHS R&D small grants scheme 2021 Funder: University Hospital Southampton R&D Closing date: 26 January 2022 Grant applications are invited from investigators across the Southampton Partnership for research funding proposals that align with research portfolios within UHS clinical divisions, and/or the UHS/UoS research infrastructure. Up to £ 50k is available for projects up to three years in duration. The application form is available here . Southampton Hospitals Charity - research funding scheme Funder: Southampton Hospitals Charity Closing date: 26 January 2022 Southampton Hospitals Charity (SHC) has partnered with the Research & Development team to fund innovative research projects with the potential to demonstrate direct benefit to UHS patients. The total number of projects awarded will be determined by quality and impact. An exceptionally strong case for funding should be presented for any project costing over £ 50k. Fundraising will launch once the successful projects have been selected and projects are therefore not expected to commence until 9-12 months after award confirmation i.e., not before January 2023. All research designs, disciplines, and scope, except for basic science projects, will be considered. SHC has identified a number of research areas for this round, based on the potential for timely fundraising: cancer care cardiology child health, including neonatal neurology ophthalmology The application form is available here More information NIHR i4i - dementia: digital approaches for early detection, diagnosis and stratification Funder: NIHR Closing date: 26 January 2022 The NIHR Invention for Innovation (i4i) Programme is inviting applications for a Dementia specific funding stream aimed at the research and development of digital approaches for the early detection, diagnosis and stratification of individuals with dementia. The i4i Programme supports the research and development of innovative medical technologies that have demonstrated proof-of-concept and have a clear developmental pathway towards new products for ultimate NHS use. More information MRC Neurosciences and Mental Health - funding opportunity Funder: MRC Closing date: 26 January 2022 Apply for funding for research projects focused on neurosciences and mental health. The MRC Neurosciences and Mental Health Board funds research in neurosciences, mental health and disorders of the human nervous system. The aim is to transform understanding of the physiology and behaviour of the human nervous system throughout the life course in health and in illness, as well as how to treat and prevent disorders of the brain. The research supported by UKRI includes the interactions between the nervous system and other parts of the body, the brain, mental health and physical health. They are also interested in how episodes throughout life impact on lifelong mental and neurological health. More information Leukaemia UK - John Goldman Fellowships Funder: Leukaemia UK Closing date: 31 January 2022 Leukaemia UK John Goldman Fellowships are aimed at early career researchers with a passion for science, a desire to develop new ideas and translate scientific advances into clinical practice. Successful applicants will demonstrate that they are the potential scientific/clinical leaders of the future. Their proposed research project must be novel with the capacity to make advances in our knowledge of leukaemia and related diseases and the development of new and kinder treatments. Applications are accepted from scientists and clinician-scientists working in UK universities, research institutions or hospitals. More information Pancreatic Cancer UK - joint funded clinical research fellowship Funder: Pancreatic Cancer UK & Association of Surgeons of GB and Ireland Closing date: 31 January 2022 The Association of Surgeons of Great Britain and Ireland (ASGBI) and Pancreatic Cancer UK Fellowship: Supports a Trainee or Junior Consultant (within 5 years of first appointment) with an interest in advancing the clinical management of pancreatic cancer. This individual will visit centres of excellence abroad and bring this experience back to the NHS to advance our clinical expertise within the UK. More information British Scoliosis Research Foundation - research grants Funder: BSRF Closing date: 31 January 2022 The British Scoliosis Research Foundation (BSRF) promotes research into the treatment of scoliosis in the UK. Each year the BSRF funds a great deal of research into scoliosis and periodically holds an international symposium to spread the knowledge gained from research. BSRF Research Grants are open to appropriately qualified professionals such as scientists, clinicians, and allied health professionals (nurses, psychologists or physiotherapists). All applications will be considered, however, applicants are advised to submit their proposal under one of the following three headings: Small exploratory grant New investigation grant Major research grant More information British Infection Association - project grants Funder: British Infection Association Closing date: 31 January 2022 The BIA aims to foster excellence in all aspects of clinical infection-related research by supporting patient-facing researchers-in-training to achieve high-quality clinical and basic research in the field of infection. BIA Project Grants provide consumables costs for trainees undertaking an infection-related research project in an academic centre in the UK or Ireland. It is envisaged funds would be used to support preliminary study in a field with intention of developing the work either through a research fellowship or as an independent investigator. More information The Urology Foundation - innovation and research grant Funder: The Urology Foundation Closing date: 31 January 2022 The Urology Foundation (TUF) is dedicated to beating all urology diseases through cutting-edge research and leading education and training to ensure that fewer lives will be devastated. The Urology Foundation (TUF) will fund projects up to a value of £ 60,000 that seek to use new, exciting, innovative approaches to address urological diseases and disorders. The projects must either (a) aim to create innovative treatments or devices, (b) aim to deliver innovative care pathways or (c) aim to use innovative research techniques or methods. Please note that innovation is necessary but not sufficient for a successful application. For example, a project with innovative methodology would need to lead to a practical end point and similarly, a project aiming to design an innovative treatment would need to have a practical methodology. More information Daphne Jackson Trust and the Kennedy Trust for Rheumatology Research - rheumatology fellowship Funder: Daphne Jackson Trust & Kennedy Trust for Rheumatology Research Closing date: 31 January 2022 Applications are invited for a Kennedy Trust sponsored three year Daphne Jackson Fellowship to be held at any UK university or research establishment. The Fellowship is intended for a scientist wishing to return to research into any clinical or pre-clinical subject in the field of rheumatology and related musculoskeletal or immunological diseases More information Diabetes UK Harry Keen intermediate clinical fellowship Funder: Diabetes UK Closing date: January 2022 The Diabetes UK Harry Keen Intermediate Clinical Fellowship allows outstanding medically qualified professionals and other clinically qualified professionals – including nurses, pharmacists and members of the Allied Health Professions, who have gained a PhD or equivalent (e.g. MD (Res)) – to establish themselves as independent researchers with a view to a long-term career as a clinical research leader in the field of diabetes. It is expected that the app
Url: /ClinicalResearchinSouthampton/For-researchers/Grant-funding-support/Current-funding-calls/Current-funding-calls.aspx

BRC Assistant Project Manager_ Study Manager PS_15 11 2023

Description: EMPLOYMENT CRITERIA / PERSON SPECIFICATION The purpose of this specification is to identify the attributes required by applicants to perform the duties in the job description. The specification will be used to shortlist applicants and to compare how well candidates match the agreed specification. It will also be used by potential candidates to understand expectations and identify how their skills, behaviours and experience will be assessed. Post Title Assistant Clinical Research Project Manager / Study Manager Directorate/Department Southampton NIHR Biomedical Research Centre Assessment Method Key (Note for candidates: This is not an exhaustive list and if you have any questions about the assessment methods listed, please contact the team member named on the job advert.) Interview These criteria will be assessed during an interview, should you be shortlisted. Application These criteria will be assessed at shortlisting; therefore anything not advised in your application can not be scored. Presentation During an interview you may be asked to produce a presentation, this is when these criteria will be assessed. Physical requirements of the post Requirements Health and physical abilities sufficient for the post (if necessary with reasonable adjustments with respect to the Equality Act/Disability Discrimination Act). Assessment Method Application Qualifications / training required Requirements Educated to degree level or equivalent Specialist qualification or significant experience In Project Management Evidence of on-going professional development International Conference on Harmonisation/Good Clinical Practice (ICH/GCP) training Previous or relevant experience necessary Assessment Method Application Application and Interview Application and Interview Application Essential X Desirable Essential x x x x Desirable EMPLOYMENT CRITERIA / PERSON SPECIFICATION The purpose of this specification is to identify the attributes required by applicants to perform the duties in the job description. The specification will be used to shortlist applicants and to compare how well candidates match the agreed specification. It will also be used by potential candidates to understand expectations and identify how their skills, behaviours and experience will be assessed. Requirements Experience in research management Research background Advanced understanding of Microsoft applications for managing and analysing information, e.g. Word and Excel Awareness of current legislation regarding research governance issues Significant experience in conducting or organising clinical research trials within NHS setting Recent experience in project management of large/complex studies Knowledge of UK Framework for Health and Social Care Research Recent NHS experience Experience of managing a study portfolio within a large organisation Experience or a detailed knowledge of the UK trial regulatory submission process Aptitudes and skills required Requirements Motivation for research Exceptional attention to detail Good organisational skills Able to work alone or as part of a team Able to prioritise tasks and cope with deadlines Proactive attitude Clear and polite verbal communication Ability to work under own initiative and independently outside the department without direct supervision. Mature and sound judgement, with ability to solve problems Assessment Method Application and Interview Application and Interview Application Application and Interview Application and Interview Application and Interview Application and Interview Application Application and Interview Application and Interview Assessment Method Application and Interview Application and Interview Application and Interview Application and Interview Application and Interview Application and Interview Application and Interview Application and Interview Application and Interview Essential x x x Desirable x x x x x x x Essential x x x x x x x x x Desirable EMPLOYMENT CRITERIA / PERSON SPECIFICATION The purpose of this specification is to identify the attributes required by applicants to perform the duties in the job description. The specification will be used to shortlist applicants and to compare how well candidates match the agreed specification. It will also be used by potential candidates to understand expectations and identify how their skills, behaviours and experience will be assessed. Special requirements of the post Requirements Ability to attend training courses and meetings on and off site Assessment Method Interview Essential x Desirable Values and behaviours Requirements Able to demonstrate behaviours that meet the Trust Values • Patients First • Always Improving • Working Together Assessment Method Application and Interview Essential Desirable X
Url: /Media/Southampton-Clinical-Research/Downloads/BRC-Assistant-Project-Manager-Study-Manager-PS-15-11-2023.pdf

Free Training: Pre-doctoral Clinical Academic Fellowship (PCAF) Scheme Workshop

Description: Auto Generated Title Free training for nurses, midwives and allied health professionals. Have you ever wanted to undertake research as part of your clinical career? Have you ever thought of doing a PhD? Then read on... Information about the scheme The NIHR launches the Pre-doctoral Clinical Academic Fellowship (PCAF) scheme annually, as part of the Integrated Clinical Academic (ICA) pathway for Nurses, Midwives and Allied Health Professionals wishing to pursue a clinical academic career. The HEE/NIHR ICA Pre-doctoral Clinical Academic Fellowship (PCAF) scheme supports early career researchers from the ICA Eligible Professions , who are committed to a clinical academic career, to become competitive applicants for a peer-reviewed doctoral level research training fellowship. The PCAF scheme offers salaried time to prepare an application for a competitive, peer reviewed doctoral level research training fellowship and funding for personalised programmes of academic training that equip awardees with the skills and experience to access doctoral level funding. We anticipate that Round 4 PCAF scheme will open for applications late January 2021. For more information about the scheme, such as launch date, award uptake options and scope of funding please click here . The funding panel Chair ’ s report is attached. He wrote: "At the end of a PCAF award, applicants should be in a position to submit a competitive Doctoral Fellowship application. Applicants are advised to develop their PCAF training proposal with this in mind, identifying any areas of weakness that need to be addressed over the course of the award." What we offer UHS is keen to support people thinking of applying for this scheme. To help people get ahead of the game, SoAR is running a PCAF workshop to assist with preparation of applications for the scheme. The workshop will give you an opportunity to hear from a number of experts such as; one of last year ’ s funding panel, a successful PCAF applicant and a member of the Research Design Service. Please see the attached programme for our exciting line up. The workshop The workshop will be held on: Date: Thursday 19th November 2020 Time: 13:00 -16:00hrs Place: Virtual via Teams Join Microsoft Teams Meeting Learn more about Teams | Meeting options Please register to attend the event here .
Url: /ClinicalResearchinSouthampton/For-researchers/Education-and-training/Events/Free-Training-Pre-doctoral-Clinical-Academic-Fellowship-PCAF-Scheme-Workshop.aspx

Grant writing bursary scheme

Description: Information for prospective applicants on University Hospital Southampton R&D research grant writing bursary scheme What is the opportunity? Research Design Service (RDS) is offering a unique opportunity for busy health, social care and public health professionals across England to attend a three-day residential grant development and writing retreat 10-12 September 2018 (to be held in Canterbury), with dedicated time to rapidly progress their research proposal. The retreat will provide a supportive environment for individuals or teams of two or three, to develop high quality research proposals prior to application to national peerreviewed funding programmes. Preference will be given to proposals for NIHR schemes, although applications to other funders of applied health and social care research will also be considered. RDS invite applications from individuals or teams of two or three people, at least one of whom must be a health or social care professional working in England. Follow this link for more details about the Retreat and for the application form: https://www.nihr.ac.uk/about-us/how-we-are-managed/ourstructure/research/research-design-service/grant-development-and-writingretreat.htm When is the retreat? The three-day residential retreat will be held 10-12 September 2018 in Canterbury, Kent. The deadline for applications is 6 June 2018. What financial support is there available for me to attend the retreat? RDS will offer successful applicants a free place at the retreat including food and accommodation. Southampton Academy of Research (SoAR) is offering bursaries to UHS employed staff who are offered a place on the retreat to support release from clinical duties and travel costs. For staff employed by the University of Southampton with an honorary contract with UHS, and intending to work on a research proposal involving Trust employed staff as applicants, travel expenses only are will be available. What will the bursary pay for? For UHS employed staff the bursary will include: 1. Up to five days salary backfill. Three days to attend the three-day retreat, and an additional two days to develop preparatory material so you can make best sue of the time at the retreat e.g. undertake literature searching, drafting research idea. 2. Costs of travel (in line with Trust policy) Up to five bursaries are available, of up to ?2,000 per person. In the event more places are allocated than funding available, the total funding will be allocated on a pro rata basis amongst applicants. For university employed staff the bursary will only include travel expenses. When will I know if I have a place? Applicants will be notified whether they have been offered a place on the retreat and a bursary no later than 30 June 2018. What are the conditions of the bursary? You will be expected to submit an application for research grant funding within 12 months of attending the retreat. Staff (team) attending the retreat will be required to submit a short report 6 and 12 months following attendance. Where do I get further information? About the retreat: contact RDS South Central via rds.sc@nihr.ac.uk or 023 8120 4778 About the bursaries: contact the SoAR administrator via soar@uhs.nhs.uk or 023 8120 3919
Url: /Media/Southampton-Clinical-Research/SoAR/Grant-writing-bursary-scheme.pdf

Form 034 Research Sponsorship Intention to Apply Form v3 Aug 2024 Clean

Description: Research Sponsorship Intention to Apply Form Please complete the information below as fully as possible. Section 1 – Applicant Details Title/Name Principal employer: Work Address: Department Telephone Applicant holds UHS Substantive or Honorary Contract: Email Substantive Honorary Applying No Position Section 2 – Funding details Funding Body NB If a grant is to be held by a commercial company please tick commercial company below and give further details. NB If investigator led, commercial funding application please tick commercial company and give further details. National Institute of Health Research (NIHR) If NIHR which funding stream? e.g. Research for Patient Benefit Medical Research Council Department of Health Other Research Council Other Govt Dept Research Charities European Union Commercial Company Please give detail: Other, please state: Particular Funding Call? Application Submission Deadline Stage 1 or Stage 2 Application? Stage 1 Stage 2 Funding amount? (GBP) Will UHS be lead Applicant? Yes No If No, please specify which organisation will be lead: Is UHS being requested to Sponsor? Yes No If UHS is not lead applicant but is being requested to sponsor please justify request: Please List Main Collaborators: Section 3 – Study Details Study/proposal/program title Proposed dates Start Date: Overall End date: Length of Follow-up: Lay Summary (no more than 500 words): Approximately how many centres do you anticipate becoming involved in the study? Where will the sites be located: Within the UK Outside UK If the study is multi-site is there a plan for the study to be managed by a Clinical Trials Unit (CTU) or Clinical Research Organisation (CRO)? Yes No If ‘yes’ please provide the name of the CTU/CRO If ‘no’ please describe how the study will be managed? i.e., study trial manager/coordinator. Approximately how many participants do you anticipate being recruited to the study? Is this a platform study? Yes No If ‘yes’ please complete the following How many sub-protocols/sub-trials will be involved? Will all sites be expected to complete all sub-protocols/sub-trials? Yes No How many different drug suppliers will be involved? Section 4 – Study Identification Please identify the category your study/proposal/program best fits. Clinical trial of an investigational medicinal product Clinical investigation or other study of a medical device Combined trial of an investigational medicinal product and an investigational medical device Other clinical trial to study a novel intervention or randomised clinical trial to compare interventions in clinical practice Basic science study involving procedures with human participants Study administering questionnaires/interviews for quantitative analysis, or using mixed quantitative/qualitative methodology Study involving qualitative methods only Study limited to working with human tissue samples (or other human biological samples) and data (specific project only) Study limited to working with data (specific project only) Research tissue bank Research database Other study Please return this completed form to sponsor@uhs.nhs.uk For R&D Office Use Only Sponsorship Portfolio Manager Comment: UHS to be named as sponsor on application form? Yes No PPI required Clinical Research Network consulted Division where CI/PI is based: Sponsorship Portfolio Manager Name: Signature Date Page 2 of 3 Research Sponsorship Intention to Apply Form Version 3 August 2024
Url: /Media/Southampton-Clinical-Research/Grants/Download/Form-034-Research-Sponsorship-Intention-to-Apply-Form-v3-Aug-2024-Clean.docx

Workforce Race Equality Standard annual report 2024

Description: Executive Summary WRES Data has been submitted by the Trust since 2015 and progress is reviewed against the nine indicators contained within the WRES dashboard quarterly. This report: • Shows the latest dataset from 2024 • Explores whether there have been any significant improvements or deterioration compared with the results from 2023. • Contains an updated WRES action plan showing the areas of focus for the Trust in the coming year. Key Observations: • BME applicants slightly more likely to be recruited. • BME staff continue to be less likely to enter a formal disciplinary process. • Perception of opportunities for career progression or promotion has increased for BME staff. • Reduction in BME staff reporting personal experience of discrimination at work by a Manager/Team leader or other colleagues. • BME staff are less likely to access non-mandatory training and CPD opportunities • Increase in BME staff experiencing harassment, bullying or abuse from patients with a widening gap of staff experience. • BME staff are almost twice as likely to report personally experiencing discrimination at work by a Manager/Team Leader or other colleagues. • The board voting membership is not reflective of the wider organisation decreasing from the 2023 data. The key findings from the 2024 submission show: 1. BME staff represent 29.8% of the workforce (3.5% increase from the 2023 data submission) showing a continuing overall improvement in proportionate representation since 2023, with the clinical workforce showing the highest increases and decreases across their workforce. 2. The data shows that BME applicants are slightly more likely to be recruited over white candidates, which may be due to continued international recruitment of Band 5 staff nurses. This continues to be a positive improvement. (Data from Trac automatic download into ESR) 3. Despite a small increase in numbers, BME staff continue to be less likely to enter a formal disciplinary process compared with white staff. 4. BME staff continue to be less likely to access non-mandatory training and Continued Professional Development opportunities compared with White staff. 5. BME staff experiencing harassment, bullying or abuse from patients, relatives or the public has increased by 3%, but has reduced for white staff. Meaning the disparity of experience of staff has increased by 4.57% further widening the gap of staff experience between white and BME staff. 6. This years’ data indicates that both white and BME staff have experienced more harassment, bullying or abuse by staff compared to last year. With larger increases for BME staff compared to white staff. 7. The perception around equal opportunities for career progression or promotion within the Trust has lessened for white staff but increased for BME staff. 8. BME staff are almost twice as likely as white staff to report personally experiencing discrimination at work by a Manager/Team leader or other colleagues, however this has reduced since the 2023 data submission. The data also shows a slight increase for white staff. 9. The board voting membership is not reflective of the wider organisation with a difference of 20%. The full data can be seen in Appendix 1. The outcomes of the WRES does not alter the themes contained in our strategy, and the action plan is aligned to these themes: 1. Inclusive recruitment practices and equal opportunities: Large scale review of current recruitment practices to eliminate bias from the systems and promote inclusivity. The Inclusive Recruitment Programme will ensure that recruiting managers are trained in inclusive recruitment techniques and criterion based methods will ensure bias is removed. We will align with the national programme for overhauling recruitment and promotion and contribute to this work wherever possible. The implementation and embedding of processes that ensure inclusive recruitment and equal opportunities for all. This will be in line with the National 6 high impact actions. Our talent management programme will provide further opportunities for people from BME backgrounds to access development and the review of processes for data collection in terms of training, development, recording as part of the data dashboard workstream will ensure the intelligence is available to correctly measure whether we are improving access or if there is more action required. 2. Workforce reflecting our wider communities: In line with the Inclusive Recruitment programme, we will be increasing efforts to make recruitment processes inclusive and therefore not post any barriers to the community in terms of applying for roles at UHS. We are anticipating the showcasing of a specific project we have collaborated with Black History Month South on exploring a multi-generational view from current and previous staff members at UHS. Our next steps will be focusing on outreach to the black communities in Southampton to promote roles and careers within UHS. Our recruitment outreach will also work more with local communities to attract people from the city from diverse backgrounds. We will be implementing positive action talent programmes that will enable people from black and ethnic backgrounds to access development, networking, and coaching to confidently apply and be successful at roles when they become available. We will provide career toolkits for all people who are unsuccessful at interviews to help them to succeed next time. We will continue to strive to meet the national target of 19% representation in band 7s and above. 3. Safe and healthy working environments: Our Inclusion and Belonging strategy states a clear intent for UHS to become an anti-racist and anti-discriminatory organisation. We aim to decrease disparity of experience by 5% across all indicators in the WRES which will either reduce by half or eliminate disparity altogether. We will be working closer with colleagues who lead on hate crime, violence and aggression to ensure robust mechanisms for reporting of incidence and the data is used to steer accountability and meaningful action. We will identify mechanisms and root causes of the disproportionality of BME staff experiencing discrimination, harassment, bullying and/or abuse and in turn whether there are trends within the Trust that need targeted action. The link to the leadership and management work programme is a critical enabler of creating safe and healthy work environments. 4. Inclusive leadership and management: Ensure leaders and managers are clear on their accountabilities with regards to EDI and the responsibilities they hold to deliver the actions within the Inclusion and Belonging strategy. To have development opportunities in supporting BME staff and those who may identify with a protected characteristic. That all leaders and managers understand their own bias and can access learning in terms of how they lead and make decisions. To support leaders and managers to understand their role as allies and role models, and how to challenge behaviours or actions that are not in line with Trust policy or values. To support leader and managers to develop greater awareness of the legal aspects of their roles in relation to equality, and how diversity and difference can enhance their team delivery and performance. Appendix 1: WRES Action Plan 2024 WRES Themes / Areas Proposed actions Responsible for Actions 1: Workforce reflecting our communities, at all roles, at all levels; ensuring those who are underrepresented groups can access support to thrive, excel and belong within their roles. Achieve 19% BME representation through all levels in both the clinical and non-clinical workforce. This is aligned to National target set and we will remain focused on increasing representation within senior leadership roles within the organisation which currently remain lower in representation of BME staff members. a) To continue to develop positive Action Programmes both UHS and HIOW system wide; for BME staff and/or other protected characteristics. Acknowledging individuals experience of barriers to promotion, development and career progression. This includes the roll out of a third cohort of the positive action leadership programme in partnership with Maaha people which will enrol a further 24 individuals who identify with a protected characteristic. Supporting individuals looking to move into, or those who are moving through senior leadership roles within the organisation building on individuals personal identify, power and influence within the organisation. OD Team with delivery partner b) Establish Talent development programmes for individuals to support their career development. Establish pathways, training and development opportunities to encourage progression at an earlier stage. Develop talent pipelines/talent management plans to include stretch activities, secondments, shadowing, specialist training, qualifications, coaching and mentoring. c) Continue to build on newly found working relationship with Southampton job centre. Continue to liaise, attend and promote UHS as an employer of choice, the support that is offered and the career opportunities that are available including volunteering roles. OD Team with delivery partner OD Team / Talent Acquisition team Deadline / review date April 2025 September 2025 April 2025 d) Continue to partner with Black History Month South on joint initiatives within the Southampton Community. e) Ensure international recruits are given the same access to development opportunities as the wider workforce. Create a clear personal development plan OD Team Throughout 2024/2025 Clinical Education Teams / OD Team December 2025 / Line Managers 2: Safe and healthy working environments, free from aggression, hate and discrimination 3: Recruitment processes which are free from bias and are inclusive 4: Inclusive leadership and management Continue to include Inclusive Leadership content in all UHS leadership & management focused on fulfilling potential and opportunities for career progression including positive action programmes. a) Creation of a behaviour framework to bring to life our Trust Values and more clearly describe the expected behaviours relating to equality, diversity and inclusion that impact BME staff and/or those with a protected characteristic. b) Divisional EDI Steering Groups to drive actions and improvements derived from race specific metrics throughout all teams, care groups and divisions. OD Team/Transformation Team Divisional Leadership Teams March 2025 April 2025 c) Carry out impact analysis on the Actionable Allyship training delivered since 2021. OD Team Propose next stage of Allyship Culture Development within UHS. Identify methodology of participation for new starters. April 2025 d) Establish and refresh approach to tackling race-related violence and aggression including marketing campaign, training for staff, and effective policies and processes. Chief People Officer / Chief Nursing April 2025 Officer e) Implement the ethnicity pay gap reporting process on an annual basis and related actions. OD Team / HR 30th March 2025 a) Continue to implement a work programme to review and improve the equity of recruitment processes and practices that impact all individuals. Deliverables this year will be: • the revised recruitment and selection training. • define the role of independent panellists and appropriate training. • ensure job advertisements and descriptions are written in clear, easy-to-read language. • review of recruitment and selection policy to ensure process is fair and free from bias. a) All board members to agree an EDI focused objective as part of their appraisal linked to a theme in the Inclusion and Belonging Strategy. OD Team / Talent Acquisition / April 2025 Training and Development / HRBPs / Recruiting Managers Chair / Director of OD Appraisal Year 2024/2025 programmes to include personal learning, personal action and accountability. This will move us to a place where equality, diversity and inclusion is the golden thread that runs through all our processes at UHS. 5: Networks and partnerships that thrive and support creation of an inclusive and safe place to work. b) Implementation of ongoing learning and development opportunities to enable leaders and managers to role model inclusive behaviours every day. For example: - Equality impact assessment - Creating environments for people to succeed - Support the development of reciprocal mentoring - Inclusive leadership behaviours aligned to our values - Focus on Heritage Celebrations and increasing leadership awareness and understanding. c) Establish development for line managers and teams who welcome international recruits to maintain their own cultural awareness and to create inclusive team cultures that embed psychological safety a) Engage with members of the One Voice Network to identify future purpose, membership and leadership of the network to ensure sustainability. OD Team / UHS Leaders & Managers OD Team / UHS Leaders & Managers OD Team April 2025 March 2026 March 2025 Appendix 1 Workforce Race Equality Standard (WRES) 2023 From my observations, it is reassuring to see improvements across indicator 1, 2 and 4. The data suggests that indicator 9 remains static with no improvement or decline, whilst indicator 3 has declined in one sense but as a whole remains more positive for staff from Black, Asian and under-represented backgrounds. Unfortunately there is a noticeable decline in indicators 5, 6, 7 and 8 which are relating to staff experience where results are sourced from the annual staff survey. The key findings from the 2024 submissions show: 10. BME staff represent 29.8% of the workforce (3.5% increase from the 2023 data submission) showing a continuing overall improvement in proportionate representation since 2023, with the clinical workforce showing the highest increases and decreases across their workforce. 11. The data shows that BME applicants are slightly more likely to be recruited over white candidates, which may be due to continued international recruitment of Band 5 staff nurses. This continues to be a positive improvement. (Data from Trac automatic download into ESR) 12. Despite a small increase in numbers, BME staff continue to be less likely to enter a formal disciplinary process compared with white staff. 13. BME staff continue to be less likely to access non-mandatory training and Continued Professional Development opportunities compared with White staff. 14. BME staff experiencing harassment, bullying or abuse from patients, relatives or the public has increased by 3%, but has reduced for white staff. Meaning the disparity of experience of staff has increased by 4.57% further widening the gap of staff experience between white and BME staff. 15. This years’ data indicates that both white and BME staff have experienced more harassment, bullying or abuse by staff compared to last year. With larger increases for BME staff compared to white staff. 16. The perception around equal opportunities for career progression or promotion within the Trust has lessened for white staff but increased for BME staff. 17. BME staff are almost twice as likely as white staff to report personally experiencing discrimination at work by a Manager/Team leader or other colleagues, however this has reduced since the 2023 data submission. The data also shows a slight increase for white staff. 18. The board voting membership is not reflective of the wider organisation with a difference of 20%. Indicator 1 Non-Clinical Non Clinical Workforce Band 1 Band 2 Band 3 Band 4 Band 5 Band 6 Band 7 Band 8A Band 8B Band 8C Band 8D Band 9 Total 2023 White BME # %#% 22 91.7% 2 8.3% 636 83.5% 126 16.5% 641 84.1% 121 15.9% 386 89.6% 253 82.4% 45 10.4% 54 17.6% 216 88.5% 28 11.5% 188 87% 28 13% 138 93.2% 10 6.8% 66 93% 5 7% 42 93.3% 3 6.6% 22 100% 0 0% 13 86.7% 2 13.3% 2623 86.1% 424 13.9% Total # 24 762 762 431 307 244 216 148 71 45 22 15 3047 White 2024 BME # % # 16 94.1% 1 % 5.9% 618 78.4% 155 19.7% 625 80.3% 141 18.1% 406 85.8% 59 12.5% 255 81.5% 53 16.9% 219 84.6% 34 13.1% 198 86.1% 29 12.6% 144 90.6% 9 5.7% 70 89.7% 7 9% 43 89.6% 2 4.2% 25 92.6% 1 3.7% 13 81.3% 2 12.5% 2632 84.22% 493 15.78% Total # 17 773 766 465 308 253 227 153 77 45 26 15 3125 Change from 2023/2024 in BME % -2.4% +3.2% +2.2% +2.1% -0.7% +1.6% -0.4% -1.1% +2% -2.4% +3.7% -0.8% +1.88% Clinical Clinical 2023 Workforc e White BME Total Band 1 Band 2 Band 3 Band 4 Band 5 Band 6 Band 7 Band 8A Band 8B Band 8C Band 8D Band 9 Consultan ts # % # % 0 0 0 0 920 71% 377 29% 408 85.9% 437 70.3% 1153 48.8% 1508 78.4% 67 14.1% 185 29.7% 1208 51.2% 415 21.6% 990 87.6% 140 12.4% 297 89.7% 81 91% 24 88.9% 13 100% 2 100% 693 74.5% 34 10.3% 8 9% 3 11.1% 0 0% 0 0% 237 25.5% # 0 1297 475 622 2361 1923 1130 331 89 27 13 2 930 White 2024 BME # 0 883 % 0 62.58% # % 0 0 495 35.08% 362 80.27% 83 18.4% 428 71.69% 139 23.28% 1150 42.03% 1390 50.8% 1400 74.59% 442 23.55% 1082 85.74% 169 13.39% 325 88.32% 40 10.87% 94 91.26% 20 76.92% 7 6.8% 5 19.23% 12 92.31% 2 100% 663 70.53% 0 0 0 0 259 27.55% Total # 0 1378 445 567 2540 1842 1251 365 101 25 12 2 922 Chan ge from 2023/ 2024 in BME % 0 +6.08 % +4.30 % -6.42% -0.40% +1.95 % +0.99 % +0.57 % -2.20% +8.13 % 0% 0% +2.05 % NonConsultan t Career Grades Trainee Grades Total 356 67.8% 169 32.2% 525 542 51.6% 508 48.4% 1050 7,424 69% 3,351 31% 10,775 87 69.6% 27 21.6% 114 - 10.60 % 546 46.91% 562 48.28% 1108 -0.12% 7054 66.1% 3618 33.9% 10672 +2.9% The 2024 data submission indicates that 29.8% of the workforce are individuals from Black, Asian and Under-represented backgrounds, which is a 3.5% increase from the 2023 data submission. BME representation of staff both clinical (2.9%) and non-clinical (1.88%) has increased. There has been BME at Bands 8A to 8D clinical (6.5%) and non-clinical (2.2%). It is notable that 50.8% of BME staff compared to 42.03% of white staff work in Band 5 clinical roles throughout the organisation, this gap has widened by 2.97% compared to 2023 data. Notable percentage changes non-clinical: Increases: Band 8D +3.7% Band 2 +3.2% Decreases: Band 1 -2.4% Band 8C -2.4% Notable percentage changes clinical: Increases: Band 2 +6.08% Band 8C +8.13% Decreases: Non Consultant Career Grades -10.6% Band 4 -6.42% Indicator 2: Relative likelihood of BME staff being appointed from shortlisting Relative likelihood of staff being appointed from shortlisting across all posts Number of shortlisted applicants Number appointed from shortlisting Relative likelihood of White staff being appointed from shortlisting compared to BME staff 2023 White BME # 6599 # 2346 1665 803 0.74 2024 White # 6323 1068 BME # 2480 702 0.596 The 2024 data collection identifies the relative likelihood of white applicants being appointed from shortlisting in comparison to BME applicants. The data shows that BME applicants are slightly more likely to be recruited over white candidates, with a relative likelihood of 0.596 in favour of BME applicants, this may be due to continued international recruitment of Band 5 staff nurses. This continues to be a positive improvement. Indicator 3: Relative likelihood of staff entering a formal disciplinary process Relative likelihood of staff entering the formal disciplinary process, as measured by entry into a formal process Number of staff entering the formal disciplinary process Relative likelihood of BME staff entering the formal disciplinary process compared to White staff 2023 White # BME # 49 16 0.87 2024 White BME # # 69 27 0.922 BME staff are less likely to enter a formal disciplinary process compared with white staff. Although there has been a slight increase this year from 0.87 to 0.922, the relative likelihood remains below 1. Indicator 4: Relative likelihood of staff accessing non-mandatory training and CPD Relative likelihood of staff accessing non-mandatory training and CPD Number of staff accessing non-mandatory training and CPD Relative likelihood of White staff accessing non-mandatory training and CPD compared to BME staff 2023 White BME # # 1167 332 1.31 2024 White BME # # 618 201 1.30 BME staff are less likely to access non-mandatory training and CPD as compared with White staff, keeping stable from 2023. This is arguably not a significant enough improvement in reducing the disparity and achieve a relative likelihood score that is closer to or equal to 1. Indicator 5: Percentage of staff experiencing harassment, bullying or abuse from patients, relatives, or the public 2023 – White: 24.62%, BME: 27.69% 2024 – White: 23.05%, BME: 30.7% In contrast to last year, the percentage of white staff experiencing harassment, bullying or abuse from patients, relatives or the public is reported at 23.05% and has decreased by 1.55%. The percentage for BME staff is reported as 30.7% which is an increase of 3%. The disparity of experience of staff has increased from 3.07% to 7.65% which is an increase of 4.58% widening the gap further. Indicator 6: Percentage of staff experiencing harassment, bullying or abuse from staff 2023 – White: 18.5%, BME: 25.3% 2024 – White: 20.77%, BME: 27.93% This years’ data indicates that both White and BME staff have experienced more harassment, bullying or abuse by staff compared to last year. The data also demonstrates that the disparity has increased slightly from 6.83% to 7.16%. Indicator 7: Percentage of staff believing that the Trust provides equal opportunities for career progression or promotion 2023 – White: 65.2%, BME: 52.4% 2024 – White: 63.04%, BME: 55.06% The disparity gap this year has decreased by 4.87% compared to last year, however this years’ data indicates the perception of White staff on the opportunities for career progression has lessened by 2.16%, and increased for BME staff by 2.66%. Indicator 8: Percentage of staff personally experiencing discrimination at work by a manager/team leader or other colleagues 2023 – White: 5.84%, BME: 15.73% disparity 9.89 2024 – White: 6.72%, BME: 12.76% disparity 6.04 (lessened by 3.85%) This years’ data submission shows a decrease of 2.97% in BME staff experiencing discrimination at work by a Manager/team leader, and a decrease in disparity of 3.85%. However it does show an increase for White staff by 0.88%. Indicator 9: % difference between the organisations’ Board voting membership and its overall workforce The % between the organisations’ Board Voting member its overall workforce representation is -20%, showing that the board voting membership is not reflective of the wider organisation.
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Equality-reports/UHS-WRES-report-2024.pdf

SHC_application_2021_final2

Description: Southampton Hospitals Charity Research Funding Award 2022 Southampton Hospitals Charity (SHC) has actively engaged in raising funds for research projects over many years. The Charity recognises that pioneering clinical and healthcare research plays a critical role at UHS as a teaching hospital and is vital to delivering improved patient care across all areas. The Charity has a unique relationship with its donors and has the capacity to harness their philanthropy to achieve significant healthcare benefits through investment in projects that represent value for money, have scientific merit and measurable impact, and are aligned to local priorities. Southampton Hospitals Charity has undertaken to support innovative research projects with the potential to demonstrate direct benefit to UHS patients. Seed funding for proof of concept or small projects will be raised to enable clinicians and researchers to prove their hypotheses, gather preliminary data and secure future grants. Key information Southampton Hospitals Charity will raise funds of up £100k for research proposals within this scheme. The total number of projects awarded will be determined by quality and impact. An exceptionally strong case for funding should be presented for any project costing over £50k. Fundraising will launch once the successful projects have been selected. Projects are therefore not expected to commence until 9-12 months after award confirmation i.e. not before January 2023. All research designs, disciplines, and scope, except for basic science projects, will be considered. SHC has identified a number of research areas for this round, based on the potential for timely fundraising: * cancer care * cardiology * child health, including neonatal * neurology * ophthalmology Projects may or may not consider conditions related to COVID-19 – it is not a requirement. Individuals, research teams or multi-organisational groups may apply, provided the lead applicant holds a substantive or honorary contract with University Hospital Southampton Foundation Trust (UHS). Projects should last no longer than two years. Projects will be expected to pump prime larger projects, further successful grant applications or clinical trials within three years. Which costs are eligible? The award will fund direct research costs, including the salaries of research or technical support staff, consumables, travel, public and patient engagement and involvement activities, and dissemination costs. Research equipment costs (purchase, maintenance, licences or software) up to £5k will be considered. As projects funded by this scheme are not eligible for automatic CRN portfolio adoption, any service support costs must either be costed within the grant or covered by external sources. Which costs are ineligible? Charitable funds are not a substitute for government funding of basic healthcare provided by the NHS. For example, this award will not cover core NHS posts, staff statutory training, or equipment that is essential to the maintenance of clinical service. Basic science projects are not eligible to apply to this current scheme. The award will not cover applicant, co-applicant or collaborators’ salaries or consultancy fees, any indirect costs such as administrative, depreciation or maintenance costs, or other overheads. Costing template Proposals will be costed by the UHS R&D grants team and successful projects will be hosted by UHS. The current costing template is available here. Requests to R&D for costs must be made via researchgrants@uhs.nhs.uk at least 10 working days before the full application deadline – UHS R&D reserves the right to reject requests received after this point. If appropriate, costs from other institutions must be sought from the correct finance office and be clearly identified in the final calculation. FEC will not be paid on University of Southampton costs and should be excluded in the final submission. Review process Scheme launch – 15 November 2021 Deadline for full applications and costing template – 26 January 2022 Applications will only be accepted via a fully completed application form – appendix A – and costing template to researchgrants@uhs.nhs.uk. Projects are expected to consider the NIHR carbon reduction guidelines relating to research (https://www.nihr.ac.uk/documents/the-nihr-carbon-reduction-guidelines/21685) in line with the UHS strategic commitment to sustainability (https://www.uhs.nhs.uk/AboutTheTrust/Sustainability-at-UHS/Sustainability-at-UHS.aspx) Applications will be assessed by a panel convened under the direction of the UHS R&D Director in February 2022. The panel will be drawn from UHS and UoS researchers with appropriate experience. The feasibility of fundraising for the shortlist of potential research projects will be considered by Southampton Hospitals Charity before the final awards are selected. Successful projects will be confirmed by 31 March 2022. It is expected that fundraising will be completed within a maximum of 12 months, enabling projects to start in Q4 2022/23 (i.e. between January to March 2023). If alternative funding from external sources becomes available, the researcher must inform UHS R&D grants immediately. In this case, the Charity may consider a revised project, e.g. additional research activities. SHC reserves the right to withdraw the offer of funds or allocate any funds already raised to another project. Appendix A – application form Lead applicant details Full name Title Telephone No Email address Current post & Division Employment contract with UHS UHS Substantive / UHS honorary Research proposal Proposal title Proposal start and finish dates* (*Project start date is dependent on fundraising by SHC and is unlikely to be before January 2023. Project duration is up to 2 years.) Project details – lay summary Include: * Background * Objectives * Project design * Outcomes 1500 words max Research partners * Detail your research team – names, post, and description of role/contribution to this project * Will this proposal involve collaboration with other organisations across the H&IoW region? Please detail. Research impact * Provide details of plans to realise impact on patients, public and/or health and care services, including timescales, at a regional or national level. * Approximate size of population to be impacted * How will this award enable future activity? 500 words max Budget and resources Detail the budget required for this project in Year 1 and Year 2 (if applicable). Please attach a copy of the UHS R&D costing template to your application. Existing support Detail any funding or in-kind support already committed to deliver this project. Alternative funding support Is this proposal under consideration by any other funder? If yes, please detail. Additional information Is there any further information that may support your application? SHC engagement & fundraising * Do you consent to being involved with the Charity to support fundraising efforts? * What is the key message to communicate to potential funders? 500 words max Research sustainability How will this project meet NIHR guidance and the UHS strategic commitment to sustainability? 500 words max Authorisation PLEASE ENSURE THAT YOU HAVE SECURED AGREEMENT FROM YOUR HEAD OF DEPARTMENT OR R&D LEAD TO SUBMIT THIS PROPOSAL AND FOR THE LEAD APPLICANT TO ACT IN THE CAPACITY OF CHIEF INVESTIGATOR SHOULD THE FUNDING BE AWARDED Head of department or R&D lead name and email address Head of department or R&D lead signature Applicant signature Date of application Send your completed application form and costing template to researchgrants@uhs.nhs.uk Closing date for submissions: 26 January 2022 SHC_application_2021_final2 6
Url: /Media/Southampton-Clinical-Research/Grants/Download/SHC-application-2021-final2.docx

Call for Expressions of Interest_BRC Research Theme Lead

Description: Call for Expressions of Interest: NIHR Southampton BRC Theme Lead 2022-2027 The University of Southampton NHS Foundation Trust (UHS) and University of Southampton (UoS) partnership are inviting expressions of interest for the role of Theme Lead for the NIHR Southampton BRC Theme Lead in i) Respiratory and Critical Care Medicine and ii) Nutrition, 2022-2027, subject to Southampton being awarded a BRC from 2022. Successful applicants will act as theme lead designates during the preparations for the NIHR Southampton BRC 2022-2027 competition, and subsequently as theme leads, subject to the relevant theme being awarded as part of an overall successful application for a BRC from 2022. Postholders will be appointed for 30 months fixed term contract, renewable for a further 30 months subject to the agreement of the UHS/UoS Partnership (total 5 years). Applicants should be a senior clinical academic with national/international standing as a leader in their field, with knowledge and experience of experimental medicine. Applicants should demonstrate: * sustained record of excellence in research activities as indicated through high impact publications and citations in experimental research. * experience interdisciplinary and collaborative working within and beyond Southampton * track record with working with industry and other research institutes to generate external income. * sustained record of excellence in teaching and learning activities in experimental medicine * experience of patient involvement/engagement activities related to experimental medicine. NIHR Biomedical Research Centres Formed through partnerships between England’s leading NHS organisations and universities, NIHR Biomedical Research Centres (BRCs) conduct experimental research to transform scientific breakthroughs into life-saving treatments for patients. Staffed by expert investigators and clinicians, NIHR BRCs are leaders in translating lab-based discoveries into new cutting edge treatments, technologies, diagnostics and other interventions in clinical settings. The aims of NIHR BRCs are to: * drive innovation in the prevention, diagnosis and treatment of ill-health * translate advances in biomedical research into benefits for patients * provide a key component of the NHS contribution to our nation’s international competitiveness by making the best Centres even better. NIHR Southampton BRC The NIHR Southampton BRC 2022/23-2026/27 will build on the success of the previous award and thus applications for the Theme Lead role will be open to current theme leads and senior researchers engaged with the current BRC. The Theme Lead will be appointed to lead the application for their theme and contribute to the overall BRC application for the next NIHR funding application, working closely with the BRC director designate. Expressions of interested should be made through submission of an up to date curriculum vitae (CV) to mandy.fripp@uhs.nhs.uk. The deadline for submissions of expressions of interest is 10th September 2020. We welcome informal discussion regarding the role, for further information please contact Professor Mike Grocott, Director Designate, between 1st September and 9th September. Expressions of interest will be shortlisted. An interview will be scheduled for shortlisted applicants. See attached for job description and person specification.
Url: /Media/Southampton-Clinical-Research/Downloads/Call-for-Expressions-of-Interest-BRC-Research-Theme-Lead.docx

1 to 10 of 122

Previous 1 2 3 4 5 … Next

Browse site A to Z

Search results

Targeting-Shared-Mechanisms-Call-1

Expression of interest form

Current funding calls

BRC Assistant Project Manager_ Study Manager PS_15 11 2023

Free Training: Pre-doctoral Clinical Academic Fellowship (PCAF) Scheme Workshop

Grant writing bursary scheme

Form 034 Research Sponsorship Intention to Apply Form v3 Aug 2024 Clean

Workforce Race Equality Standard annual report 2024

SHC_application_2021_final2

Call for Expressions of Interest_BRC Research Theme Lead

Site policies

Contact details

Useful links